USPTO serial 87318001
TAKEDA 1 POINT
Reviewed by CopyMark Law Group
Reg. 5885765Status 711
- Filing date
- Status date
- Registration date
- Oct 15, 2019
- Examiner
- HELFMAN, JUDITH MICHELLE
- Law office
- TMO LAW OFFICE 111
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TAKEDA 1 POINT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Takeda Pharmaceutical Company Limited
Osaka, JP
Other trademarks owned by Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
Osaka, JP
Other trademarks owned by Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
Osaka 540-8645, JP
Other trademarks owned by Takeda Pharmaceutical Company Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karl M. Zielaznicki, Esq.
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP875 Third Avenuec/o IP Services NYCNew York, NY 10022Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business administration of patient reimbursement program; business administration of medication reimbursement programs and services | SECTION 7(e) - CANCELLED | Aug 27, 2018 |
| 036 | Financial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information | SECTION 7(e) - CANCELLED | Aug 27, 2018 |
| 044 | Providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer auto-immune diseases and inflammatory diseases and disorders | SECTION 7(e) - CANCELLED | Aug 27, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Takeda Pharmaceutical Company Limited
- Other trademarks owned by Takeda Pharmaceutical Company Limited
- Other trademarks owned by Takeda Pharmaceutical Company Limited
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 044
- Similar marks named TAKEDA 1 POINT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 1, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 1, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 1, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 1, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 13, 2020 | NCS8 | NOTICE OF CANCELLATION SEC. 8 EMAILED | — |
| Feb 12, 2020 | C7.. | CANCELLED SECTION 7-TOTAL | — |
| Feb 12, 2020 | NCS7 | NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED | — |
| Feb 5, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 6, 2020 | C7RF | REQUEST FOR SECT 7 TOTAL SURRENDER FILED | — |
| Jan 6, 2020 | ES7S | TEAS SECTION 7 SURRENDER RECEIVED | — |
| Oct 15, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 11, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 10, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 9, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 9, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 5, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 6, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2019 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 27, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 8, 2019 | IUAF | USE AMENDMENT FILED | — |
| Feb 8, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 11, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 9, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 9, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 9, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 22, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 13, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 19, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 29, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 11, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 11, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 11, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 11, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 11, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 9, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 9, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 16, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 16, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 15, 2017 | ALIE | ASSIGNED TO LIE | — |
| Oct 1, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 13, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 13, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 13, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 19, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 19, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 19, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 19, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 11, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 17, 2017 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 17, 2017 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 17, 2017 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 14, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 3, 2017 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 2, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 2, 2017 | NWAP | NEW APPLICATION ENTERED | — |